F13.932
Sedative, hypnotic or anxiolytic use, unspecified with withdrawal with perceptual disturbances
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F13.932 refers to a condition involving the use of sedative, hypnotic, or anxiolytic medications, which are drugs typically prescribed to manage anxiety, sleep disorders, or stress. This particular code indicates that the individual has experienced withdrawal symptoms following discontinuation or reduction of these medications, and that these withdrawal symptoms include perceptual disturbances—alterations in perception such as hallucinations or altered sensory experiences. Recognizing this condition is vital for healthcare providers to manage the withdrawal process safely and effectively.
Causes & Symptoms
Clinical Causes: Prolonged or high-dose use of sedative, hypnotic, or anxiolytic medications Sudden discontinuation or rapid reduction of these medications Inadequate medical supervision during medication tapering Underlying mental health conditions that predispose to dependence
Key Symptoms: Perceptual disturbances such as hallucinations (seeing, hearing, or feeling things that are not present) Anxiety or agitation Insomnia or sleep disturbances Nausea or vomiting Dizziness or lightheadedness Tremors or muscle agitation Sweating and increased heart rate Confusion or disorientation
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive clinical evaluation, including a detailed history of medication use, timing and nature of withdrawal symptoms, and physical and mental health assessments. Healthcare providers may utilize standardized scales to assess withdrawal severity and rule out other causes of perceptual disturbances. Monitoring for the presence of hallucinations or other perceptual changes during the withdrawal process is particularly important.
Treatment Protocols: Gradual tapering of the offending medication under medical supervision to minimize withdrawal symptoms Supportive care such as hydration, rest, and reassurance Use of alternative medications to manage withdrawal symptoms, if appropriate Psychological support or counseling to address anxiety and underlying mental health issues Monitoring for safety and severity of perceptual disturbances, with hospitalization if symptoms are severe or pose safety concerns Addressing any co-existing mental health conditions
Clinical Advice & FAQs
Billing Guidance
Is F13.932 a billable ICD-10 code?
Yes, F13.932 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.932?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic use, unspecified with withdrawal with perceptual disturbances and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
